Michael R Hamblin Ph.D. is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and in low-level light therapy (LLLT) for wound healing, arthritis, traumatic brain injury and hair-regrowth. He directs a laboratory of around a sixteen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published 252 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 8 patents. He is Associate Editor for 7 journals, on the editorial board of a further 12 journals and serves on NIH Study Sections. For the past 9 years Dr Hamblin has chaired an annual conference at SPIE Photonics West entitled "Mechanisms for low level light therapy" and he has edited the 9 proceedings volumes together with four other major textbooks on PDT and photomedicine. He has several other book projects in progress at various stages of completion. In 2011 Dr Hamblin was honored by election as a Fellow of SPIE. Pinar Avci, MD is a Research Fellow in Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School Department of Dermatology, Boston USA. She received her MD degree in General Medicine from Semmelweis University, and is currently pursuing her PhD in Department of Dermatology, Venereology and Dermato-oncology, Semmelweis University, Budapest, Hungary. She is currently conducting research in the area of Photodynamic therapy (PDT) – a localized approach for treatment of cancer and infections and its effects in developing anti-tumor immunity. In 2004, Dr Prow earned his Ph.D. from the University of Texas in the field of Nanomedicine. He then completed his T32 funded post-doc at the Wilmer Eye Institute at The Johns Hopkins Hospital and was faculty there until he relocated to the University of Queensland in Brisbane, Australia in 2007. In 2011 Dr Prow became the Deputy Director of the Dermatology Research Centre. In 2015, Dr Prow was promoted to Associate Professor within the University of Queensland's School of Medicine. He leads a NHMRC and ARC funded team that focuses on drug delivery, diagnostics and imaging in the context of dermatology.

• 1. Anatomy and Function of the SkinYolanda Gilaberte, Lucia Prieto-Torres, Ievgenia Pastushenko and Ángeles Juarranz2. Fundamentals of Nanoscience (and Nanotechnology)G. Louis Hornyak and Anil K. Rao3. An Overview of Nanomaterials in DermatologyBreanne Mordorski, Angelo Landriscina, Adam Friedman4. Clinical Impact and Patient Safety: The Potential of Microneedles in Changing the Form and Perception of Transdermal Drug DeliveryAaron J. Brady and Ryan F. Donnelly5. Inorganic nanoparticles for transdermal drug delivery and topical applicationMin Wang, Srujan Kumar Marepally, Praveen Kumar Vemula and Chenjie Xu6. Biodegradable, Biocompatible and Bioconjugate Materials as Delivery Agents in DermatologyFiorenza Rancan7. Peptide Dendrimers in Delivery of Bioactive Molecules to SkinJyothsna Menon, Aswathi R Hegde, Harendra S. Parekh and Srinivas Mutalik8. Insights into Interactions of Gold Nanoparticles with the Skin and Potential Dermatological ApplicationsNesma El-Sayed, Labiba El-Khourdagui and Marc Schneider9. Formulation Effects on Topical Nanoparticle PenetrationHeather A.E. Benson, Yousuf Mohammed, Jeffrey E. Grice, Michael S. Roberts10. Nitric Oxide-Releasing Nanoparticles as an Antimicrobial TherapeuticJamie Rosen, Angelo Landriscina, and Joshua D. Nosanchuk11. Nanoparticles in the topical treatment of cutaneous Leishmaniasis: gaps, facts and perspectivesSocorro Espuelas, Juana Schwartz and Esther Moreno12. Nanotechnology based nano-bullets in antipsoriatic drug delivery: state of the artMahfoozur Rahman, Sarwar Beg ,  Firoz Anwar, and Vikas Kumar13. Nanoparticles for Treatment of atopic dermatitisMona M. A. Abdel-Mottaleb14. Challenges and opportunities of nanoparticle-based theranostics in skin cancerStefania Pizzimenti, Chiara Dianzani, Gian Paolo Zara, Carlo Ferretti, Federica Rossi, Casimiro Luca Gigliotti, Martina Daga, Eric Stefano Ciamporcero, Giovanni Maina and Giuseppina Barrera15. Nanodelivery of anti-cancer agents in melanoma: encouraging but a long way to goJiezhong Chen and Xu Dong Zhang16. Targeted Nanoparticles for Drug Delivery to Melanoma: From Bench to BedsideJun Li, Yi Zhang and Juan Tao17. The Potential for Metal Nanoparticle Enhanced Radiotherapy in DermatologyVan L.T. Hoang, Matthew C. Foote, Tarl W. Prow18. Nanotechnology in PhotoprotectionLucy L. Chen, Steven Q. Wang19. Nanoemulsions to Prevent PhotoagingAllesandro Afornali and Márcio Lorencini20. Decoupling hazard from risk in using sunscreens containing metal oxide nanoparticlesMegan J. Osmond McLeod21. Nanoparticle Oxygen Sensing in SkinZongxi Li and Conor L. Evans22. Investigating the intracellular dynamics of Hypericin loaded nanoparticles and polyvinylpyrrolidone-Hypericin by image correlation spectroscopyRozhin Penjweini, Sarah Deville, Anitha Ethirajan and Marcel Ameloot23. Accelerated Wound Healing Using NanoparticlesEe Teng Goh, Georgia Kirby, Jayakumar Rajadas, Xing-Jie Liang and Aaron Tan24. Migration through naturally existing barriers and distribution of QDs in the skinRicardas Rotomskis25. Nanomedicines for the Eye: Current Status and Future DevelopmentAnthony A. Attama, Joy N. Reginald-Opara, Emmanuel M. Uronnachi and Ebele B. Onuigbo26. Bioinspired Nano-Substrates for Skin RegenerationShima Tavakol, Sasan Jalili-Firoozinezhad, Omid Mashinchian and Morteza Mahmoudi27. Imaging Nanoparticle Skin Penetration in HumansLynlee L. Lin, Miko Yamada and Tarl W. Prow28. EGF-loaded Nanofibers for Skin Tissue EngineeringMohammad Norouzi and Masoud Soleimani

Michael R Hamblin Ph.D. is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and in low-level light therapy (LLLT) for wound healing, arthritis, traumatic brain injury and hair-regrowth. He directs a laboratory of around a sixteen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published 252 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 8 patents. He is Associate Editor for 7 journals, on the editorial board of a further 12 journals and serves on NIH Study Sections. For the past 9 years Dr Hamblin has chaired an annual conference at SPIE Photonics West entitled "Mechanisms for low level light therapy" and he has edited the 9 proceedings volumes together with four other major textbooks on PDT and photomedicine. He has several other book projects in progress at various stages of completion. In 2011 Dr Hamblin was honored by election as a Fellow of SPIE. Pinar Avci, MD is a Research Fellow in Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School Department of Dermatology, Boston USA. She received her MD degree in General Medicine from Semmelweis University, and is currently pursuing her PhD in Department of Dermatology, Venereology and Dermato-oncology, Semmelweis University, Budapest, Hungary. She is currently conducting research in the area of Photodynamic therapy (PDT) – a localized approach for treatment of cancer and infections and its effects in developing anti-tumor immunity. In 2004, Dr Prow earned his Ph.D. from the University of Texas in the field of Nanomedicine. He then completed his T32 funded post-doc at the Wilmer Eye Institute at The Johns Hopkins Hospital and was faculty there until he relocated to the University of Queensland in Brisbane, Australia in 2007. In 2011 Dr Prow became the Deputy Director of the Dermatology Research Centre. In 2015, Dr Prow was promoted to Associate Professor within the University of Queensland's School of Medicine. He leads a NHMRC and ARC funded team that focuses on drug delivery, diagnostics and imaging in the context of dermatology.

• 1. Anatomy and Function of the SkinYolanda Gilaberte, Lucia Prieto-Torres, Ievgenia Pastushenko and Ángeles Juarranz2. Fundamentals of Nanoscience (and Nanotechnology)G. Louis Hornyak and Anil K. Rao3. An Overview of Nanomaterials in DermatologyBreanne Mordorski, Angelo Landriscina, Adam Friedman4. Clinical Impact and Patient Safety: The Potential of Microneedles in Changing the Form and Perception of Transdermal Drug DeliveryAaron J. Brady and Ryan F. Donnelly5. Inorganic nanoparticles for transdermal drug delivery and topical applicationMin Wang, Srujan Kumar Marepally, Praveen Kumar Vemula and Chenjie Xu6. Biodegradable, Biocompatible and Bioconjugate Materials as Delivery Agents in DermatologyFiorenza Rancan7. Peptide Dendrimers in Delivery of Bioactive Molecules to SkinJyothsna Menon, Aswathi R Hegde, Harendra S. Parekh and Srinivas Mutalik8. Insights into Interactions of Gold Nanoparticles with the Skin and Potential Dermatological ApplicationsNesma El-Sayed, Labiba El-Khourdagui and Marc Schneider9. Formulation Effects on Topical Nanoparticle PenetrationHeather A.E. Benson, Yousuf Mohammed, Jeffrey E. Grice, Michael S. Roberts10. Nitric Oxide-Releasing Nanoparticles as an Antimicrobial TherapeuticJamie Rosen, Angelo Landriscina, and Joshua D. Nosanchuk11. Nanoparticles in the topical treatment of cutaneous Leishmaniasis: gaps, facts and perspectivesSocorro Espuelas, Juana Schwartz and Esther Moreno12. Nanotechnology based nano-bullets in antipsoriatic drug delivery: state of the artMahfoozur Rahman, Sarwar Beg ,  Firoz Anwar, and Vikas Kumar13. Nanoparticles for Treatment of atopic dermatitisMona M. A. Abdel-Mottaleb14. Challenges and opportunities of nanoparticle-based theranostics in skin cancerStefania Pizzimenti, Chiara Dianzani, Gian Paolo Zara, Carlo Ferretti, Federica Rossi, Casimiro Luca Gigliotti, Martina Daga, Eric Stefano Ciamporcero, Giovanni Maina and Giuseppina Barrera15. Nanodelivery of anti-cancer agents in melanoma: encouraging but a long way to goJiezhong Chen and Xu Dong Zhang16. Targeted Nanoparticles for Drug Delivery to Melanoma: From Bench to BedsideJun Li, Yi Zhang and Juan Tao17. The Potential for Metal Nanoparticle Enhanced Radiotherapy in DermatologyVan L.T. Hoang, Matthew C. Foote, Tarl W. Prow18. Nanotechnology in PhotoprotectionLucy L. Chen, Steven Q. Wang19. Nanoemulsions to Prevent PhotoagingAllesandro Afornali and Márcio Lorencini20. Decoupling hazard from risk in using sunscreens containing metal oxide nanoparticlesMegan J. Osmond McLeod21. Nanoparticle Oxygen Sensing in SkinZongxi Li and Conor L. Evans22. Investigating the intracellular dynamics of Hypericin loaded nanoparticles and polyvinylpyrrolidone-Hypericin by image correlation spectroscopyRozhin Penjweini, Sarah Deville, Anitha Ethirajan and Marcel Ameloot23. Accelerated Wound Healing Using NanoparticlesEe Teng Goh, Georgia Kirby, Jayakumar Rajadas, Xing-Jie Liang and Aaron Tan24. Migration through naturally existing barriers and distribution of QDs in the skinRicardas Rotomskis25. Nanomedicines for the Eye: Current Status and Future DevelopmentAnthony A. Attama, Joy N. Reginald-Opara, Emmanuel M. Uronnachi and Ebele B. Onuigbo26. Bioinspired Nano-Substrates for Skin RegenerationShima Tavakol, Sasan Jalili-Firoozinezhad, Omid Mashinchian and Morteza Mahmoudi27. Imaging Nanoparticle Skin Penetration in HumansLynlee L. Lin, Miko Yamada and Tarl W. Prow28. EGF-loaded Nanofibers for Skin Tissue EngineeringMohammad Norouzi and Masoud Soleimani

Michael R Hamblin Ph.D. is a Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology. He was trained as a synthetic organic chemist and received his PhD from Trent University in England. His research interests lie in the areas of photodynamic therapy (PDT) for infections, cancer, and heart disease and in low-level light therapy (LLLT) for wound healing, arthritis, traumatic brain injury and hair-regrowth. He directs a laboratory of around a sixteen post-doctoral fellows, visiting scientists and graduate students. His research program is supported by NIH, CDMRP, USAFOSR and CIMIT among other funding agencies. He has published 252 peer-reviewed articles, over 150 conference proceedings, book chapters and International abstracts and holds 8 patents. He is Associate Editor for 7 journals, on the editorial board of a further 12 journals and serves on NIH Study Sections. For the past 9 years Dr Hamblin has chaired an annual conference at SPIE Photonics West entitled "Mechanisms for low level light therapy" and he has edited the 9 proceedings volumes together with four other major textbooks on PDT and photomedicine. He has several other book projects in progress at various stages of completion. In 2011 Dr Hamblin was honored by election as a Fellow of SPIE. Pinar Avci, MD is a Research Fellow in Wellman Center for Photomedicine, Massachusetts General Hospital and Harvard Medical School Department of Dermatology, Boston USA. She received her MD degree in General Medicine from Semmelweis University, and is currently pursuing her PhD in Department of Dermatology, Venereology and Dermato-oncology, Semmelweis University, Budapest, Hungary. She is currently conducting research in the area of Photodynamic therapy (PDT) – a localized approach for treatment of cancer and infections and its effects in developing anti-tumor immunity. In 2004, Dr Prow earned his Ph.D. from the University of Texas in the field of Nanomedicine. He then completed his T32 funded post-doc at the Wilmer Eye Institute at The Johns Hopkins Hospital and was faculty there until he relocated to the University of Queensland in Brisbane, Australia in 2007. In 2011 Dr Prow became the Deputy Director of the Dermatology Research Centre. In 2015, Dr Prow was promoted to Associate Professor within the University of Queensland's School of Medicine. He leads a NHMRC and ARC funded team that focuses on drug delivery, diagnostics and imaging in the context of dermatology.

• 1. Anatomy and Function of the SkinYolanda Gilaberte, Lucia Prieto-Torres, Ievgenia Pastushenko and Ángeles Juarranz2. Fundamentals of Nanoscience (and Nanotechnology)G. Louis Hornyak and Anil K. Rao3. An Overview of Nanomaterials in DermatologyBreanne Mordorski, Angelo Landriscina, Adam Friedman4. Clinical Impact and Patient Safety: The Potential of Microneedles in Changing the Form and Perception of Transdermal Drug DeliveryAaron J. Brady and Ryan F. Donnelly5. Inorganic nanoparticles for transdermal drug delivery and topical applicationMin Wang, Srujan Kumar Marepally, Praveen Kumar Vemula and Chenjie Xu6. Biodegradable, Biocompatible and Bioconjugate Materials as Delivery Agents in DermatologyFiorenza Rancan7. Peptide Dendrimers in Delivery of Bioactive Molecules to SkinJyothsna Menon, Aswathi R Hegde, Harendra S. Parekh and Srinivas Mutalik8. Insights into Interactions of Gold Nanoparticles with the Skin and Potential Dermatological ApplicationsNesma El-Sayed, Labiba El-Khourdagui and Marc Schneider9. Formulation Effects on Topical Nanoparticle PenetrationHeather A.E. Benson, Yousuf Mohammed, Jeffrey E. Grice, Michael S. Roberts10. Nitric Oxide-Releasing Nanoparticles as an Antimicrobial TherapeuticJamie Rosen, Angelo Landriscina, and Joshua D. Nosanchuk11. Nanoparticles in the topical treatment of cutaneous Leishmaniasis: gaps, facts and perspectivesSocorro Espuelas, Juana Schwartz and Esther Moreno12. Nanotechnology based nano-bullets in antipsoriatic drug delivery: state of the artMahfoozur Rahman, Sarwar Beg ,  Firoz Anwar, and Vikas Kumar13. Nanoparticles for Treatment of atopic dermatitisMona M. A. Abdel-Mottaleb14. Challenges and opportunities of nanoparticle-based theranostics in skin cancerStefania Pizzimenti, Chiara Dianzani, Gian Paolo Zara, Carlo Ferretti, Federica Rossi, Casimiro Luca Gigliotti, Martina Daga, Eric Stefano Ciamporcero, Giovanni Maina and Giuseppina Barrera15. Nanodelivery of anti-cancer agents in melanoma: encouraging but a long way to goJiezhong Chen and Xu Dong Zhang16. Targeted Nanoparticles for Drug Delivery to Melanoma: From Bench to BedsideJun Li, Yi Zhang and Juan Tao17. The Potential for Metal Nanoparticle Enhanced Radiotherapy in DermatologyVan L.T. Hoang, Matthew C. Foote, Tarl W. Prow18. Nanotechnology in PhotoprotectionLucy L. Chen, Steven Q. Wang19. Nanoemulsions to Prevent PhotoagingAllesandro Afornali and Márcio Lorencini20. Decoupling hazard from risk in using sunscreens containing metal oxide nanoparticlesMegan J. Osmond McLeod21. Nanoparticle Oxygen Sensing in SkinZongxi Li and Conor L. Evans22. Investigating the intracellular dynamics of Hypericin loaded nanoparticles and polyvinylpyrrolidone-Hypericin by image correlation spectroscopyRozhin Penjweini, Sarah Deville, Anitha Ethirajan and Marcel Ameloot23. Accelerated Wound Healing Using NanoparticlesEe Teng Goh, Georgia Kirby, Jayakumar Rajadas, Xing-Jie Liang and Aaron Tan24. Migration through naturally existing barriers and distribution of QDs in the skinRicardas Rotomskis25. Nanomedicines for the Eye: Current Status and Future DevelopmentAnthony A. Attama, Joy N. Reginald-Opara, Emmanuel M. Uronnachi and Ebele B. Onuigbo26. Bioinspired Nano-Substrates for Skin RegenerationShima Tavakol, Sasan Jalili-Firoozinezhad, Omid Mashinchian and Morteza Mahmoudi27. Imaging Nanoparticle Skin Penetration in HumansLynlee L. Lin, Miko Yamada and Tarl W. Prow28. EGF-loaded Nanofibers for Skin Tissue EngineeringMohammad Norouzi and Masoud Soleimani